Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells
- 1 July 2014
- journal article
- Published by Elsevier in Respiratory Investigation
- Vol. 52 (4) , 251-260
Abstract
No abstract availableKeywords
Funding Information
- Health, Labour and Welfare Sciences Research Grants (H23-Nanchi-Ippan-024)
This publication has 44 references indexed in Scilit:
- Tulobuterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cellsPhysiological Reports, 2013
- Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responsesRespiratory Research, 2013
- Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in gliomaOncogene, 2012
- Increased Cytokine Response of Rhinovirus-infected Airway Epithelial Cells in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Quantification of mRNA using real-time RT-PCRNature Protocols, 2006
- Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary diseaseEuropean Respiratory Journal, 2003
- Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblastsThorax, 2002
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation.Journal of Clinical Investigation, 1996
- Relationship between lung tissue and blood plasma concentrations of inhaled budesonideBiopharmaceutics & Drug Disposition, 1993